Latest news
New analysis explains why bone marrow cancer T cells may need therapeutic activation - Medical XpressMedical Xpress · Mon, 10 Aug 2026 20:00:06 GMTFirst-in-Class RNA Degrader Targets Historically ‘Undruggable’ MYC in Preclinical Multiple Myeloma Models - Pharmacy TimesPharmacy Times · Mon, 10 Aug 2026 19:16:31 GMTWhat the ENDURANCE Trial Reveals About Discontinuing Lenalidomide in Myeloma - Targeted OncologyTargeted Oncology · Mon, 10 Aug 2026 16:52:16 GMTFive Under 5: Top Oncology Videos for the Week of 8/2 - OncLiveOncLive · Sun, 09 Aug 2026 10:23:10 GMTePRO Monitoring: Earlier Intervention, Fewer Hospitalizations - Targeted OncologyTargeted Oncology · Fri, 07 Aug 2026 22:00:00 GMTRethinking Myeloma Lenalidomide Maintenance - Oncology Nursing NewsOncology Nursing News · Fri, 07 Aug 2026 13:10:33 GMTThe Future of Myeloma Care: Home Administration - Targeted OncologyTargeted Oncology · Thu, 06 Aug 2026 22:00:00 GMTReacting to the FDA Advisory Committee Verdict on RP1 in Melanoma - Targeted OncologyTargeted Oncology · Wed, 05 Aug 2026 19:00:00 GMT